Application of CHROMagar candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata

Journal of Clinical Microbiology

Volumn 34, Issue 1, 1996, Pages 58-61

  Pfaller, M A ^a   Houston, A ^a   Coffmann, S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATION; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA TROPICALIS; COLONY FORMATION; CULTURE MEDIUM; FUNGUS CULTURE; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ADULT; AGAR; CANDIDA; CANDIDA ALBICANS; COMPARATIVE STUDY; CULTURE MEDIA; EVALUATION STUDIES; HUMAN; INFANT, NEWBORN; MYCOLOGY; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0029655530     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Louwagie, B., I. Surmont, J. Verhaegen, and F. Odds. 1995. Difierential and enrichment media for selective culture and recognition of yeast species from clinical material Eur. J. Clin. Microbiol. Infect Dis. 14:406-411.
2. Moyer, G. J., M. Romagnoli, and W. G. Merz. 1095. CHROMagar for presumptive identification and detection of multiple yeast species in oncology surveillance, abstr F-117, p. 107. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
3. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
4. Pfaller, M. A. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis., in press.
5. Pfaller, M. A. 1995. Epidemiology of fungal infections. J. Hosp. Infect 30(Suppl):329-338.
6. Pfaller, M. A., I. Cabezudo, F. Koontz, M. Bale, and R. Gingrich. 1987. Predictive value of surveillance cultures for systemic infection due to Candida species Eur. J Clin. Microbiol. 6:628-633.
7. Pfaller, M. A., S. A. Messer, and S. Coffmann. 1995. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870. J. Clin Microbiol. 33:1094-1097.
8. Pfaller, M. A., T. Preston, M. Bale, F. P. Koontz, and B. A. Body. 1988. Comparison of Quantum II. API Yeast Ident, and AutoMicrobic System for the identification of clinical yeast isolates. J. Clin. Microbiol 26:2054-2058.
9. Price, M. F., M. T. LaRocco, and L. O. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother 38:1422-1424.
10. Reagan, D. R., M. A. Pfaller, R. J. Hollis, and R. P. Wenzel. 1990. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J. Clin Microbiol. 28:2733-2738.
11. Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb for the NIAID Mycoses Study Group and the Candidemia Study Group. 1994. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B for treatment of nonneutropenic patients with candidemia. Antimcrob. Agents Chemother. 39:40-44.
12. Sandford, G. R., W. G. Merz, J. R. Wingard, P. Charache, and R. Saral. 1980 The value of fungal surveillance cultures as predictors of systemic fungal infections. J. Infect. Dis. 142:503-509
13. Voss, A., R. J. Hollis, M. A. Pfaller, R. P. Wenzel, and B. N. Doebbeling. 1994. Investigation of the sequence of colonization and candidemia in non-neutropenic patients. J. Clin. Microbiol 32:975-980.
14. Warren, N. G., and K. C. Hazen. 1995. Candida, Cryptococcus, and other yeasts of medical importance, p 723-737 In P. R Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C
15. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.